Detalles de la búsqueda
1.
Nivolumab combined docetaxel versus nivolumab in patients with previously treated nonsmall cell lung cancer: a phase 2 study.
Anticancer Drugs
; 35(5): 412-417, 2024 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38240789
2.
Construction of an endoplasmic reticulum stress-related signature in lung adenocarcinoma by comprehensive bioinformatics analysis.
BMC Pulm Med
; 23(1): 172, 2023 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37189138
3.
Evaluation of efficacy and toxicity of nivolumab combined with or without docetaxel in patients with advanced NSCLC.
Cancer Immunol Immunother
; 71(2): 267-276, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34131807
4.
A phase II study of anlotinib in 45 patients with relapsed small cell lung cancer.
Int J Cancer
; 147(12): 3453-3460, 2020 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-32557583
5.
Clinical characteristics associated with non-small-cell lung cancer harboring ALK rearrangements in Chinese patients.
Future Oncol
; 12(10): 1243-9, 2016 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-26888425
6.
Real-world data on the first-line immune checkpoint inhibitors or in combination with chemotherapy in older patients (aged ≥ 75 years) with advanced non-small cell lung cancer.
Heliyon
; 10(4): e26026, 2024 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38390071
7.
Aneuploid subtypes of circulating tumor cells and circulating tumor-derived endothelial cells predict the overall survival of advanced lung cancer.
Front Oncol
; 13: 829054, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37213309
8.
Second-line treatment options in advanced thymic carcinoma after failure of platinum-based chemotherapy: A multicenter retrospective study.
Cancer Med
; 12(3): 2303-2311, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35924403
9.
The overall survival benefit in Chinese ALK+ NSCLC patients received targeted therapies.
J Thorac Dis
; 14(6): 2201-2212, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35813748
10.
Comparison of endostatin combined with PT-DC versus bevacizumab combined with PT-DC in the first-line treatment of advanced lung adenocarcinoma: a retrospective propensity score-matched cohort study.
Ann Palliat Med
; 10(7): 7847-7856, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34353072
11.
Immune-Related Adverse Events and Their Association With the Effectiveness of PD-1/PD-L1 Inhibitors in Non-Small Cell Lung Cancer: A Real-World Study From China.
Front Oncol
; 11: 607531, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-33747922
12.
Pembrolizumab or Bevacizumab Plus Chemotherapy as First-Line Treatment of Advanced Nonsquamous Nonsmall Cell Lung Cancer: A Retrospective Cohort Study.
Technol Cancer Res Treat
; 20: 15330338211039676, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34821175
13.
Prognostic factor analysis of patients with small cell lung cancer: Real-world data from 988 patients.
Thorac Cancer
; 12(12): 1841-1850, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33955685
14.
Efficacy and toxicities of gemcitabine and cisplatin combined with endostar in advanced thymoma and thymic carcinoma.
Thorac Cancer
; 10(1): 17-23, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30411854
15.
Salvage treatment with anlotinib for advanced non-small cell lung cancer.
Thorac Cancer
; 10(7): 1590-1596, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31183998
16.
[Impact of hepatitis B virus infected serum on the hepatic differentiation of human bone marrow mesenchymal stem cells].
Beijing Da Xue Xue Bao Yi Xue Ban
; 40(5): 459-64, 2008 Oct 18.
Artículo
en Zh
| MEDLINE | ID: mdl-18931705
17.
Efficacy, safety and predictive indicators of apatinib after multilines treatment in advanced nonsquamous nonsmall cell lung cancer: Apatinib treatment in nonsquamous NSCLC.
Asia Pac J Clin Oncol
; 14(6): 446-452, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-29573236
18.
Efficacy and safety of extended use of platinum-based doublet chemotherapy plus endostatin in patients with advanced nonsmall cell lung cancer.
Medicine (Baltimore)
; 95(28): e4183, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27428214
19.
[Timing of Brain Radiation Therapy Impacts Outcomes in Patients with â©Non-small Cell Lung Cancer Who Develop Brain Metastases].
Zhongguo Fei Ai Za Zhi
; 19(8): 508-14, 2016 Aug 20.
Artículo
en Zh
| MEDLINE | ID: mdl-27561799
20.
Circulating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics.
Thorac Cancer
; 6(4): 534-8, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-26273411